VKTX Stock Crashes After 22% Weight Loss at Week 33: Why Viking Therapeutics Got a Cold Market Shoulder
Viking Therapeutics’ VK2735 maintenance data showed continued weight loss with no plateau and clear placebo separation at week 33, yet VKTX stock fell sharply. The...